Chandra Asri stock: Profitability weakens despite revenue surge

Chandra Asri stock is in focus after Chemorbis reported on Tuesday, November 3, 2026, that Chandra Asri Pacific faced a sharp deterioration in profitability during the first nine months of the year despite strong revenue growth.

Revenue rose 60.5 percent year over year to 8.19 billion US dollars, compared with 5.10 billion US dollars a year earlier. The combination of higher sales and weaker profitability puts operating performance and margins at the center of the investment discussion.

Growth comes with margin pressure

The report highlights a mixed operating picture for the Indonesian petrochemical group. Stronger revenue indicates continued scale in the business, while the decline in profitability points to pressure on earnings conversion. For investors, the next results will show whether the sales momentum can translate into more stable profitability.

Expansion remains central

Chandra Asri Group describes itself as a Southeast Asian provider of energy, chemical and infrastructure solutions. Its activities include petrochemicals, infrastructure, trading and energy, supported by an integrated petrochemical complex in Indonesia and expansion across the region. The company also says its chlor-alkali and ethylene dichloride facility is approaching operations, adding to its investment program.

For broader Indonesian market developments, see current market reports.